Cabot (NYSE:CBT) Now Covered by Truist Financial

Equities researchers at Truist Financial assumed coverage on shares of Cabot (NYSE:CBT) in a report released on Monday, Marketbeat reports. The firm set a “buy” rating and a $98.00 price target on the specialty chemicals company’s stock. Truist Financial’s target price points to a potential upside of 21.20% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the company. JPMorgan Chase & Co. boosted their price objective on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Wall Street Zen cut Cabot from a “buy” rating to a “hold” rating in a report on Saturday. Mizuho increased their price target on Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Finally, UBS Group lifted their price objective on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Friday, May 8th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Cabot has a consensus rating of “Hold” and a consensus price target of $83.80.

Cabot Price Performance

CBT stock opened at $80.86 on Monday. Cabot has a 52 week low of $58.33 and a 52 week high of $89.46. The firm has a market capitalization of $4.17 billion, a P/E ratio of 15.28, a price-to-earnings-growth ratio of 10.67 and a beta of 0.82. The company has a fifty day simple moving average of $79.11 and a two-hundred day simple moving average of $73.09. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51.

Cabot (NYSE:CBT) last posted its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. The firm had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.31 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Analysts anticipate that Cabot will post 6.32 earnings per share for the current fiscal year.

Institutional Trading of Cabot

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Fuller & Thaler Asset Management Inc. grew its stake in Cabot by 5.6% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock valued at $155,315,000 after purchasing an additional 124,613 shares during the last quarter. State Street Corp boosted its holdings in shares of Cabot by 1.0% in the 4th quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock valued at $134,256,000 after buying an additional 20,021 shares in the last quarter. American Century Companies Inc. grew its position in shares of Cabot by 8.4% in the 3rd quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock worth $137,300,000 after buying an additional 140,665 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Cabot by 4.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock worth $131,253,000 after acquiring an additional 79,499 shares in the last quarter. Finally, Bank of America Corp DE raised its stake in shares of Cabot by 3.9% during the 3rd quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock worth $128,032,000 after acquiring an additional 63,080 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.